General - Press Releases

Date	Title	Company
13-Dec-2022	Empyrean Neuroscience Forms Scientific Advisory Board	Businesswire
13-Dec-2022	Takeda to Acquire Late-Stage, Potential Best-in-Class, Oral Allosteric TYK2 Inhibitor NDI-034858 From Nimbus Therapeutics	Businesswire
13-Dec-2022	Global Glycomic Therapeutics Market Forecast to 2028 - Wide Applications of Glycomics in Therapeutics Presents Opportunities - ResearchAndMarkets.com	Businesswire
13-Dec-2022	Merck Global Health Innovation Fund and P74 Ventures Make Strategic Investment in TransVoyant for Intelligent, ‘Self Aware’ Supply Chain Platform	Businesswire
13-Dec-2022	CluePoints Appoints Andy Cooper as New Chief Executive Officer	CluePoints
13-Dec-2022	The Worldwide Aminophenol Industry is Projected to Reach $1.7 Billion by 2027 - ResearchAndMarkets.com	Businesswire
13-Dec-2022	Tech in 2030 Thematic Intelligence Report - ResearchAndMarkets.com	Businesswire
13-Dec-2022	Global Polyhydroxyalkanoates (PHA) Market to 2033: Demand, Production Capacities, End User Markets and Key Players - ResearchAndMarkets.com	Businesswire
13-Dec-2022	Global Autoimmune Partnering Report and Directory 2022: Deal Trends, Players and Financials Analysis 2015-2022 - ResearchAndMarkets.com	Businesswire
13-Dec-2022	QIAGEN receives FDA approval for companion diagnostic to Mirati Therapeutics’ KRAZATI in non-small cell lung cancer	Businesswire
13-Dec-2022	FDA Modernization and Restructuring of the SDLC for Computer System Validation and Compliance Webinar - ResearchAndMarkets.com	Businesswire
13-Dec-2022	Sphere Fluidics Appoints Richard Hammond as Chief Technical Officer	Businesswire
13-Dec-2022	Global Drug Bioavailability Enhancement Summit 2023: Formulation and Delivery Technologies for Improving Drug Product Performance and Bioavailability (Princeton, NJ, United States - May 16-17, 2023) - ResearchAndMarkets.com	Businesswire
13-Dec-2022	MRM Health and IFF Reach Second Milestone in the Partnered Type 2 Diabetes Program	Businesswire
13-Dec-2022	First Trust Global Funds PLC UK Regulatory Announcement: Net Asset Value(s)	Businesswire
13-Dec-2022	Advicenne Obtains Orphan Drug Designation for ADV7103 in the United States for the Treatment of Distal Renal Tubular Acidosis (dRTA)	Businesswire
13-Dec-2022	Agilent Resolution ctDx FIRST Receives FDA Approval as a Liquid Biopsy Companion Diagnostic Test for Advanced Non-small Cell Lung Cancer	Businesswire
13-Dec-2022	JT Included in the Dow Jones Sustainability Asia Pacific Index for the Ninth Consecutive Year	Businesswire
13-Dec-2022	Kessler Topaz Meltzer & Check, LLP Announces the Firm Has Filed a Securities Fraud Class Action Lawsuit Against Twist Bioscience Corporation	Businesswire
13-Dec-2022	GI CELL Enters Agreement with Optieum Biotechnologies	Businesswire